Caudal Epidural Vs. TAP Block for Postoperative Analgesia in Pediatric Infraumbilical Surgery: a RCT
Comparison of Caudal Epidural Block and Ultrasound-Guided Transversus Abdominis Plane (TAP) Block for Postoperative Analgesia in Pediatric Infraumbilical Surgery: a Randomized Controlled Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
This randomized controlled trial investigates the postoperative analgesic efficacy of caudal epidural block versus ultrasound-guided transversus abdominis plane (TAP) block in pediatric patients undergoing infraumbilical surgery. A total of 60 pediatric patients (aged 1 to 7 years, ASA I-II) were randomly assigned to one of two groups:
- Group C (Caudal Block): Received 1 mL/kg of 0.25% bupivacaine in the caudal epidural space.
- Group T (TAP Block): Received 0.3 mL/kg of 0.25% bupivacaine injected into the transversus abdominis plane under ultrasound guidance. Primary Outcome:
- Postoperative FLACC pain scores at 2, 6, 12, and 24 hours. Secondary Outcomes:
- Total analgesic consumption (including rescue analgesia).
- Intraoperative hemodynamic parameters (heart rate, blood pressure, SpO₂).
- Incidence of nausea and vomiting (PONV).
- Parental satisfaction scores. The study aims to determine which regional anesthesia technique provides superior pain relief and reduces systemic analgesic requirements in pediatric patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable postoperative-pain
Started Dec 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2023
CompletedFirst Submitted
Initial submission to the registry
March 19, 2025
CompletedFirst Posted
Study publicly available on registry
March 26, 2025
CompletedApril 1, 2025
March 1, 2025
1 year
March 19, 2025
March 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative FLACC Pain Scores
Postoperative pain intensity was measured using the Face, Legs, Activity, Cry, Consolability (FLACC) scale at predefined time points after surgery. The FLACC scale is a validated tool for assessing postoperative pain in pediatric patients based on behavioral observations.
FLACC pain scores were recorded at 2, 6, 12, and 24 hours postoperatively
Secondary Outcomes (4)
Total Postoperative Analgesic Consumption
0-24 hours postoperatively
Intraoperative Hemodynamic Stability
Baseline, after induction, after surgical incision, and at 15, 30, 45, and 60 minutes intraoperatively.
Incidence of Postoperative Nausea and Vomiting (PONV)
0-24 hours postoperatively
Parental Satisfaction Scores
Recorded at 24 hours postoperatively and at a follow-up phone call after discharge.
Study Arms (2)
Group C - Caudal Epidural Block
EXPERIMENTALParticipants in this group received a caudal epidural block after the induction of general anesthesia. A 35-mm 22G or 30-mm 25G block needle was inserted through the sacrococcygeal ligament into the epidural space under aseptic conditions. After confirming negative aspiration for cerebrospinal fluid or blood, 1 mL/kg of 0.25% bupivacaine was administered.
Group T - Transversus Abdominis Plane (TAP) Block
EXPERIMENTALParticipants in this group received an ultrasound-guided transversus abdominis plane (TAP) block after the induction of general anesthesia. A 22G, 50-mm insulated block needle was inserted using an in-plane technique under ultrasound guidance with a linear probe. The needle was advanced into the fascial plane between the internal oblique and transversus abdominis muscles. After confirming placement with a 0.5-1 mL test dose of 0.9% NaCl and negative aspiration for blood, 0.3 mL/kg of 0.25% bupivacaine was administered.
Interventions
A caudal epidural block was performed after the induction of general anesthesia. Using a 35-mm 22G or 30-mm 25G block needle, the sacral hiatus was identified, and the needle was inserted through the sacrococcygeal ligament into the epidural space under aseptic conditions. After confirming negative aspiration for cerebrospinal fluid or blood, 1 mL/kg of 0.25% bupivacaine was administered.
A transversus abdominis plane (TAP) block was performed after the induction of general anesthesia. Using a 22G, 50-mm insulated block needle, the injection was administered under ultrasound guidance using a linear probe and in-plane technique. The needle was advanced into the fascial plane between the internal oblique and transversus abdominis muscles. After confirming placement with a 0.5-1 mL test dose of 0.9% NaCl and negative aspiration for blood, 0.3 mL/kg of 0.25% bupivacaine was administered.
0.25% bupivacaine was administered in both intervention arms as part of the regional anesthesia procedure In the Caudal Block group, 1 mL/kg of 0.25% bupivacaine was administered into the caudal epidural space. In the TAP Block group, 0.3 mL/kg of 0.25% bupivacaine was administered into the transversus abdominis plane under ultrasound guidance
Eligibility Criteria
You may qualify if:
- Pediatric patients aged 1 to 7 years.
- ASA Physical Status I-II.
- Undergoing infraumbilical abdominal surgery (e.g., hernia repair, orchiopexy, circumcision).
- Parental written informed consent obtained.
You may not qualify if:
- Contraindications to regional anesthesia, such as:
- Coagulopathy or bleeding disorders.
- Local infection at the injection site.
- Known allergy to local anesthetics.
- Neurological conditions (e.g., degenerative neuropathy, brain tumors, increased intracranial pressure).
- Intellectual disabilities affecting pain assessment.
- Chronic pain conditions or opioid use before surgery.
- Parental refusal to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tekirdag Namik Kemal University
Tekirdağ, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Onur Baran
Namik Kemal University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The study was single-blinded, with postoperative pain assessors blinded to the group allocation. The anesthesiologist administering the block was aware of the group assignment, but postoperative evaluators were not.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 19, 2025
First Posted
March 26, 2025
Study Start
December 15, 2022
Primary Completion
December 15, 2023
Study Completion
December 15, 2023
Last Updated
April 1, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share